Novilytic secures $1.6M, preps commercial launch

A made-in-Indiana startup with a tool that could save pharmaceutical companies millions of dollars when it comes to trashing contaminated drugs during the development process. In the Business of Health, Kylie Veleta has more with Novilytic Chief Executive Officer Paul Dreier.